Biopharma Dive recently published a series of articles on biotech bankruptcies. The first lists bankruptcies in 2019, while the other lists companies which are teetering towards bankruptcy. As the article notes,…
A few months ago, the Centers for Disease Control published a new analysis, concluding that the US is experiencing "a steep, sustained increases in sexually transmitted diseases." The CDC has a…
Remember me?Back in the mid-80s, when the Sony Walkman was a cassette player, companies like Upjohn, Parke-Davis, and Schering-Plough were well known in the pharmaceutical community. These names, and many others,…
Derek Lowe is a medicinal chemist with ~30-years of industry experience, mainly in Big Pharma. His very popular In The Pipeline blog is a must read for anyone who wants…
Last year was unquestionably an excellent year from an FDA NCE approval perspective. A recent article in Nature Reviews Drug Discovery has the full list. An interactive table (complete with…
That didn't take long. In mid-December, we released a short video that summarized a few items of interest from 2018. We also offered a few predictions for 2019. One of…
The good folks at Pharmaprojects just published their Pharma R&D Annual Review. A summary of the report, plus a link to the full report, is available here. The report…
Last week, an FDA Advisory committee unanimously recommended the approval of Epidiolex for the treatment of two rare forms of pediatric epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). The full…
Last week was the 20th anniversary of the launch of Viagra (sildenafil, Pfizer). Formerly known as UK-92,480, sildenafil was first synthesized at Pfizer's faculty in Kent, UK. The press…
Following up on their sobering report on drug development in depression, BIO has released another report in their State of Innovation in Highly Prevalence Chronic Diseases series. This time,…